SM

Sabby Management Portfolio holdings

AUM $12M
1-Year Est. Return 79.04%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
-79.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$77M
AUM Growth
+$48.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$31.2M
2
+$6.99M
3
+$3.94M
4
XERS icon
Xeris Biopharma Holdings
XERS
+$3.78M
5
MTVA
MetaVia Inc
MTVA
+$3.18M

Top Sells

1
+$2.89M
2
+$2.31M
3
+$2.11M
4
OTLK icon
Outlook Therapeutics
OTLK
+$1.94M
5
TRIL
Trillium Therapeutics Inc.
TRIL
+$1.78M

Sector Composition

1 Healthcare 73.45%
2 Industrials 1.66%
3 Consumer Discretionary 0.57%
4 Technology 0.52%
5 Financials 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$406K 0.53%
25,000
-17,500
27
$372K 0.48%
+59
28
$367K 0.48%
+745
29
$354K 0.46%
76,970
-30,607
30
$342K 0.44%
32,410
+11,682
31
$288K 0.37%
125,312
-314,962
32
$281K 0.36%
+20,125
33
$263K 0.34%
3,712
-20,294
34
$241K 0.31%
+2,150
35
$227K 0.29%
2,250
-5,465
36
$224K 0.29%
+1,490
37
$177K 0.23%
+2,747
38
$123K 0.16%
585,859
-421,585
39
$94K 0.12%
698
-149
40
$83K 0.11%
26
41
$80K 0.1%
+3,395
42
$69K 0.09%
+208
43
$65K 0.08%
12,925
-432,748
44
$54K 0.07%
+167
45
$35K 0.05%
56,757
-515,514
46
$34K 0.04%
+833
47
$34K 0.04%
2,726
-30,088
48
$22K 0.03%
3,220
+2,484
49
$21K 0.03%
+597
50
$18K 0.02%
+850
1
2
3 4 5